Elizabeth Volkmann, MD, on the Gut Microbiome in Systemic Sclerosis

In this podcast, Elizabeth Volkmann, MD, discusses her research into how the gut microbiome of patients with systemic sclerosis may be associated with the pathogenesis of the disease, how environmental influences may affect gut dysbiosis, and what treatments are available or being tested to address the gastrointestinal manifestations of systemic sclerosis. Read the full transcript here.

Additional Resources:

• Volkmann ER, Hoffmann-Vold AM. Gastrointestinal tract microbiota modifications in systemic sclerosis. Eur J Rheumatol. 2019;1(1):1-8. doi:10.5152/eurjrheum.2019.19103.
• Volkmann ER, Chang, YL, Barroso N, et al. Association of systemic sclerosis with a unique colonic microbial consortium. Arthritis Rheumatol. 2016;68(6):1483-1492. https://dx.doi.org/10.1002%2Fart.39572
• Volkmann ER. Intestinal microbiome in scleroderma: recent progress. Curr Opin Rheumatol. 2017;29:553-560. https://doi.org/10.1097/bor.0000000000000429
• Volkmann ER, Hoffmann-Vold AM, Chang YL, et al. Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts. BMJ Open Gastroenterol. 2017;4(1):e000134. https://doi.org/10.1136/bmjgast-2017-000134

Elizabeth Volkmann, MD, is the founder and director of the Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD) Integrative Clinic Program and director of the Scleroderma Program at the University of California Los Angeles. 

For more content on systemic sclerosis, visit our Resource Center.